EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Levels of serum lipids predict responses to PD-L1 inhibitors as first-line treatment in small cell lung cancer: an observational study

Qiaoli Chen, Ping Shu, Xia Yuan, Wei Zhang

International Journal of Clinical Pharmacy · 2024

DOI: 10.1007/s11096-024-01792-0 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Clinical Pharmacy, 2024. Verfasst von Qiaoli Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms, Immune Checkpoint Inhibitors, Lipids. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Cultivation Project of Shanghai Pulmonary Hospital, Supporting Discipline Project of Shanghai Pulmonary Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Cell Lung CarcinomaLung NeoplasmsImmune Checkpoint InhibitorsLipidsHumansMaleFemaleMiddle AgedAgedAged, 80 and overAdultRetrospective StudiesB7-H1 Antigen

Stichwörter der Autor:innen

Clinical effectImmunotherapySerum lipidsSmall cell lung cancer

Substanzen

Immune Checkpoint InhibitorsLipidsCD274 protein, humanB7-H1 Antigen

Autor:innen und Institutionen

  • Department of Pharmacy, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Pharmacy, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. jydzw1981@163.com.

Förderung

  • National Natural Science Cultivation Project of Shanghai Pulmonary Hospital
  • Supporting Discipline Project of Shanghai Pulmonary Hospital

Zitieren

APA

Chen, Q., Shu, P., Yuan, X., & Zhang, W. (2024). Levels of serum lipids predict responses to PD-L1 inhibitors as first-line treatment in small cell lung cancer: an observational study. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-024-01792-0

Vancouver

Chen Q, Shu P, Yuan X, Zhang W. Levels of serum lipids predict responses to PD-L1 inhibitors as first-line treatment in small cell lung cancer: an observational study. International Journal of Clinical Pharmacy. 2024. doi:10.1007/s11096-024-01792-0

BibTeX
@article{Chen2024,
  author = {Chen, Qiaoli and Shu, Ping and Yuan, Xia and Zhang, Wei},
  title = {Levels of serum lipids predict responses to PD-L1 inhibitors as first-line treatment in small cell lung cancer: an observational study},
  journal = {International Journal of Clinical Pharmacy},
  year = {2024},
  doi = {10.1007/s11096-024-01792-0}
}
Kostenlos starten →